Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Comparing surgical and non-surgical treatments for finger osteoarthritis

Official title: Denervation for Osteoarthritis in the PIP-joint Efficacy Study (DOPS), a Randomized Controlled Trial

Run by Karolinska Institutet · NCT05980793 · Data updated 2026-11-12

This study is testing whether surgery or non-surgical treatments like education and exercise work better for people with osteoarthritis in their finger joints.

More Bariatric Surgery trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment90 (estimated)
SponsorKarolinska Institutet
Academic / other
Locations1 site (Stockholm)
StatusRecruiting
StartedSeptember 25, 2023
Main results expectedJuly 15, 2028
Study endsJuly 15, 2029
Registry record updatedDecember 2, 2024
Trial IDNCT05980793 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older with chronic symptomatic osteoarthritis in the PIP joint and radiological evidence of the condition.

Probably not a fit

Patients with inflammatory arthritis, ongoing infections in the hand, or those who have received certain injections in the affected joint within the last three months may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the effectiveness of surgical denervation versus non-surgical treatment, which includes patient education and exercise, in patients suffering from osteoarthritis in the proximal interphalangeal (PIP) joint. Participants will be randomly assigned to one of the two treatment groups, and their pain levels, functional outcomes, grip strength, and range of motion will be assessed at baseline and at 3, 6, and 12 months post-intervention. The study seeks to determine if surgical intervention provides greater benefits compared to non-surgical methods. The primary endpoint will be evaluated 12 months after the intervention.

Why it matters

Potential benefit: If successful, this study could provide patients with more effective treatment options for managing pain and improving function in finger osteoarthritis.

How similar studies have gone: Other studies have shown promising results with surgical interventions for osteoarthritis, but this specific comparison of surgical versus non-surgical treatment for PIP joint osteoarthritis is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 18 years.
* Chronic symptomatic osteoarthritis in the PIP-joint.
* Radiological signs of osteoarthritis on posteroanterior and lateral radiographs assessed by the Kellgren-Lawrence classification (grade II-IV) (Kellgren \& Lawrence, 1957).
* Clinical signs of PIP-joint arthritis.

Exclusion Criteria:

* Inflammatory arthritis.
* Ongoing infection in the hand.
* Inability to co-operate with the follow-up protocol.
* Intra-articular glucocorticoid, PRP or Hyaluronic acid injections in the affected joint less than 3 months prior to enrollment.

Where it's running

  • Department of Hand Surgery, Södersjukhuset
    Stockholm, Sweden
    Recruiting

Study contacts

  • Principal investigator: Elin Sward, MD, PhD — Department of Hand Surgery Sodersjukhuset and Karolinska Institutet
  • Study coordinator: Elin Sward, MD, PhD
  • Email: elin.sward@regionstockholm.se
  • Phone: +46812361000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.